Skip to main content
Log in

Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C

  • Case Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

We present the case of a 53-year-old woman who developed systemic lupus erythematosus (SLE) after being treated with interferon-alpha (IFN-α) for cryoglobulinemic vasculitis associated with hepatitis C virus (HCV) infection. Her cryoglobulinemic vasculitis resolved rapidly with IFN-α treatment. However, after 10 months of IFN-α therapy, she developed a photosensitive malar rash, oral ulcers, arthralgias, lymphopenia, and anti-SSA autoantibodies. She was diagnosed with SLE induced by IFN-α therapy. IFN-α was discontinued, she was treated with a short course of prednisone and hydroxychloroquine, and she improved rapidly. This is the first report of IFN-α-induced SLE complicating treatment of cryoglobulinemic vasculitis associated with HCV infection. The development of SLE during therapy with IFN-α could be due to direct immunomodulation by IFN-α, and review of experimental data and prior case reports suggests a pathogenic role for IFN-α in SLE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ioannou Y, Isenberg DA (2000) Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. Arthritis Rheum 43:1431–1442

    Article  CAS  PubMed  Google Scholar 

  2. Krause I, Valesini G, Scrivo R, Shoenfeld Y (2003) Autoimmune aspects of cytokine and anticytokine therapies. Am J Med 115:390–397

    Article  CAS  PubMed  Google Scholar 

  3. Ronnblom LE, Alm GV, Oberg KE (1990) Possible induction of systemic lupus erythematosus by interferon-α treatment in a patient with a malignant carcinoid tumour. J Intern Med 227:207–210

    CAS  PubMed  Google Scholar 

  4. Schilling PJ, Kurzrock R, Kantarjian H, Gutterman JU, Talpaz M (1991) Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia. Cancer 68:1536–1537

    CAS  PubMed  Google Scholar 

  5. Mehta ND, Hooberman AL, Vokes EE, Neeley S, Cotler S (1992) 35-year-old patient with chronic myelogenous leukemia developing systemic lupus erythematosus after α-interferon therapy. Am J Hematol 41:141

    CAS  PubMed  Google Scholar 

  6. Tolymat A, Leventhal B, Sakarcan A, Kashima H, Monteiro C (1992) Systemic lupus erythematosus in a child receiving long-term interferon therapy. J Pediatr 120:429–432

    PubMed  Google Scholar 

  7. Wandl UB, Nagel-Hiemke M, May D, Kreuzfelder E, Kloke O, Kranzhoff M et al (1992) Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disorders. Clin Immunol Immunopathol 65:70–74

    Article  CAS  PubMed  Google Scholar 

  8. Hory B, Blanc D, Saint-Hiller Y (1992) Systemic lupus erythematosus-like syndrome induced by alpha-interferon therapy. Eur J Med 1:379

    CAS  PubMed  Google Scholar 

  9. Flores A, Olive A, Feliu E, Tena X (1994) Systemic lupus erythematosus following interferon therapy. Br J Rheumatol 33:787

    CAS  Google Scholar 

  10. Yoshida A, Takeda A, Koyama K, Morozumi K, Oikawa T (1994) Systemic lupus erythematosus with nephropathy after interferon-α 2A therapy. Clin Rheumatol 13:382

    Google Scholar 

  11. Morris LF, Lemak NA, Arnett FC, Jordon RE, Duvic M (1996) Systemic lupus erythematosus diagnosed during interferon alfa therapy. South Med J 89:810–814

    CAS  PubMed  Google Scholar 

  12. Fukuyama S, Kajiwara E, Suzuki N, Miyazaki N, Sadoshima S, Onoyama K (2000) Systemic lupus erythematosus after α-interferon therapy for chronic hepatitis C: a case report and review of the literature. Am J Gastroenterol 95:310

    CAS  PubMed  Google Scholar 

  13. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277

    CAS  PubMed  Google Scholar 

  14. Conlon KC, Urba WJ, Smith JW, Steis RG, Longo DL, Clark JW (1990) Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy. Cancer 65:2237–2242

    CAS  PubMed  Google Scholar 

  15. Kim T, Kanayama Y, Negoro N, Okamura M, Takeda T, Inoue T (1987) Serum levels of interferons in patients with systemic lupus erythematosus. Clin Exp Immunol 70:562–569

    CAS  PubMed  Google Scholar 

  16. Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J (2001) Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus. Science 294:1540–1543

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Timothy B. Niewold.

Additional information

No financial support or conflict of interest to declare

Rights and permissions

Reprints and permissions

About this article

Cite this article

Niewold, T.B., Swedler, W.I. Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C. Clin Rheumatol 24, 178–181 (2005). https://doi.org/10.1007/s10067-004-1024-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-004-1024-2

Keywords

Navigation